YASMIN PIRZADA, MD
Specialist in SWANTON, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
YASMIN PIRZADA, MD filed 1,443 Medicare Part D claims in 2023 as a Specialist in SWANTON, Ohio, prescribing 88% generic.
- 1K
- Part D claims, 2023
- 88%
- generic prescribing
- $66.14
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
YASMIN PIRZADA, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
1,443 Top 20% higher than 80% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about YASMIN PIRZADA, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Ohio
How Specialist compares to other specialties among Ohio providers
Specialist share within Ohio
Specialist is one of the more visible NUCC categories in Ohio
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Specialist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Specialist ABMS/AOA estimate
Est. board-certified rate (Specialist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Specialist US NPIs
Specialty board-certified rate — Specialist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
YASMIN PIRZADA, MD appears in the CMS NPPES registry as a Specialist provider holding MD credentials at 22 TURTLE CREEK CIR, SWANTON, OH, 43558, with a listed phone of (419) 825-5151. NPI 1871510800 was issued on 07/16/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PIRZADA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,443 prescription claims written by this provider, covering 235 Medicare beneficiaries and totaling roughly $139K in drug spend, split 12% brand-name and 88% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1871510800 |
|---|---|
| Specialty | Specialist |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/16/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm YASMIN PIRZADA, MD's current license status, disciplinary history, and board certifications with the State Medical Board of Ohio in Ohio before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for YASMIN PIRZADA, MD. Source: openpaymentsdata.cms.gov.
Total received
$66
Largest payer
Dexcom, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Ohio OMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to YASMIN PIRZADA, MD. To verify YASMIN PIRZADA, MD's current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 88% generic, on 1,443 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,155
- Total Day Supply
- 91,074
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $121K
- Generic Drug Cost
- $17K
- Antibiotic Claims
- 57
Patient Demographics
- Average Patient Age
- 69.2 years
- Avg HCC Risk Score
- 1.02
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 52, 65-74: 120, 75-84: 47, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What YASMIN PIRZADA, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
137 claims
- Lisinopril
Lisinopril
109 claims
- Amlodipine Besylate
Amlodipine Besylate
67 claims
- Levothyroxine Sodium
Levothyroxine Sodium
56 claims
- Simvastatin 40
Simvastatin
40 claims
- Metformin Hcl 36
Metformin Hcl
36 claims
- Hydrochlorothiazide 34
Hydrochlorothiazide
34 claims
- Metoprolol Succinate 31
Metoprolol Succinate
31 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 137 |
| Lisinopril | 109 |
| Amlodipine Besylate | 67 |
| Levothyroxine Sodium | 56 |
| Simvastatin | 40 |
| Metformin Hcl | 36 |
| Hydrochlorothiazide | 34 |
| Metoprolol Succinate | 31 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 27 |
| Prednisone | 26 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How YASMIN PIRZADA, MD fits within the Specialist landscape nationally.
YASMIN PIRZADA, MD's 1,443 claims are below the specialty average of 1,474.
Nearby Specialist Providers in Ohio
Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as PIRZADA.
Compare Specialist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Ohio
Frequently Asked Questions
What is YASMIN PIRZADA, MD's specialty? ▼
How much does YASMIN PIRZADA, MD prescribe under Medicare Part D? ▼
Where is YASMIN PIRZADA, MD located? ▼
What is YASMIN PIRZADA, MD's NPI number? ▼
Does YASMIN PIRZADA, MD prescribe more brand-name or generic drugs? ▼
How many Specialist providers are there in the US? ▼
What drugs does YASMIN PIRZADA, MD prescribe most often? ▼
Does YASMIN PIRZADA, MD accept Medicare? ▼
How can I verify YASMIN PIRZADA, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology